medicines
AGEFI | 13-Apr-2017
Le géant bâlois est accusé d’avoir "menacé" le ministère colombien du Commerce et de l’Industrie de recourir à un tribunal d’arbitrage international.
Public Eye | 12-Apr-2017
Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license
IA Reporter | 5-Apr-2017
Ukraine has settled a dispute with American pharmaceutical company Gilead Sciences Inc., following the company’s pursuit of legal remedies in both domestic courts and via investment arbitration.
Lexology | 27-Mar-2017
The Tribunal found that Eli Lilly had failed to demonstrate that the promise doctrine constitutes a fundamental or dramatic change in the utility requirement under Canadian patent law or that the promise doctrine is arbitrary and/or discriminatory.
People Over Profit | 7-Mar-2017
People Over Profit Statement on the 17th Round of Negotiations of the Regional Comprehensive Economic Partnership (RCEP) in Kobe, Japan 27 Feb-3 March 2017
MSF | 3-Mar-2017
Médecins Sans Frontières (MSF) raises concerns over provisions under negotiation in the RCEP investment chapter that threaten to restrict access to affordable medicines for millions of people
Sunday Guardian Live | 27-Feb-2017
There is no principled basis for EU’s demand of extending patent protection beyond the period of 20 years.
New Statesman | 5-Apr-2016
One element of TTIP has been largely ignored – the deal’s impact on developing countries.
The Clinic | 12-Feb-2016
El domingo pasado el canciller, Heraldo Muñoz, tras firmar el Acuerdo de Asociación Transpacífico, que debe ser ratificado por el Parlamento, argumentó que las críticas se debían a desinformación. La organización civil, Chile mejor sin TPP, responde al secretario de Estado y refuta sus afirmaciones sobre los beneficios que traerá para el país el cuestionado acuerdo comercial.

0 | 10 | 20